Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serological reactivity of some monoclonal antibodies to varicella-zoster virus.

Literature DB >> 6184037

Serological reactivity of some monoclonal antibodies to varicella-zoster virus.

B Forghani, N J Schmidt, C K Myoraku, D Gallo.

Abstract

Monoclonal antibodies to varicella-zoster virus, free from host cell reactivity, were produced by cell fusion technics. Antibodies from four different clones showed diverse activities in neutralization immunofluorescence and complement fixation assays. The antibodies provide useful reagents for viral diagnosis and viral antigenic characterization.

Entities: Species

Mesh：

Substances：

Year: 1982 PMID： 6184037 DOI： 10.1007/bf01318084

Source DB: PubMed Journal: Arch Virol ISSN： 0304-8608 Impact factor: 2.574

12 in total

1. Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors: G Köhler; C Milstein
Journal: Nature Date: 1975-08-07 Impact factor: 49.962

2. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors: B Forghani; N J Schmidt; J Dennis
Journal: J Clin Microbiol Date: 1978-11 Impact factor: 5.948

3. Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

Authors: B Forghani; N J Schmidt; E H Lennette
Journal: Infect Immun Date: 1976-11 Impact factor: 3.441

4. Improved yields of cell-free varicella-zoster virus.

Authors: N J Schmidt; E H Lennette
Journal: Infect Immun Date: 1976-09 Impact factor: 3.441

5. Recent studies on the isolation and characterization of Delta herpesvirus.

Authors: W P Allen; A D Felsenfeld; R H Wolf; H F Smetana
Journal: Lab Anim Sci Date: 1974-02

6. Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections.

Authors: N J Schmidt; E H Lennette; J D Woodie; H H Ho
Journal: J Lab Clin Med Date: 1965-09

7. Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies.

Authors: B Forghani; J Dennis; N J Schmidt
Journal: J Clin Microbiol Date: 1980-11 Impact factor: 5.948

8. A better cell line for making hybridomas secreting specific antibodies.

Authors: M Shulman; C D Wilde; G Köhler
Journal: Nature Date: 1978-11-16 Impact factor: 49.962

9. Neutralizing antibody responses to varicella-zoster virus.

Authors: N J Schmidt; E H Lennette
Journal: Infect Immun Date: 1975-09 Impact factor: 3.441

10. Production of monospecific antibodies to varicella zoster virus antigen in rabbits tolerant to human IgG and immunized with antigen immunoprecipitated with human IgG from zoster reconvalescent sera.

Authors: B L Hansen; B F Vestergaard; G N Hansen
Journal: J Immunol Methods Date: 1981 Impact factor: 2.303

13 in total

1. Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors: B Forghani; G J Yu; J W Hurst
Journal: J Clin Microbiol Date: 1991-03 Impact factor: 5.948

Review 2. Monoclonal antibodies: implications for virology. Brief review.

Authors: K C McCullough
Journal: Arch Virol Date: 1986 Impact factor: 2.574

3. Monoclonal antibodies to Leptospira interrogans serovar pomona.

Authors: A J Ainsworth; T L Lester; G Capley
Journal: Can J Comp Med Date: 1985-04

4. Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.

Authors: B Forghani; K W Dupuis; N J Schmidt
Journal: J Virol Date: 1984-10 Impact factor: 5.103

5. Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

Authors: R W Ellis; P M Keller; R S Lowe; R A Zivin
Journal: J Virol Date: 1985-01 Impact factor: 5.103

6. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

Authors: A J Davison; C M Edson; R W Ellis; B Forghani; D Gilden; C Grose; P M Keller; A Vafai; Z Wroblewska; K Yamanishi
Journal: J Virol Date: 1986-03 Impact factor: 5.103

7. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).

Authors: P R Kinchington; P Ling; M Pensiero; B Moss; W T Ruyechan; J Hay
Journal: J Virol Date: 1990-09 Impact factor: 5.103